skip to contentskip to secondary navigation
Getting to the centre 03 9496 5000
Make a difference
Donate
  • Patients & family
    • Becoming our patient
      • How to become an ONJ patient
      • Planning for your care
    • Diagnosis & Treatment
      • Cancer types
      • A new diagnosis
      • Cancer treatment
      • Your Wellness matters
      • Commonly asked questions
    • Clinical Haematology
      • Allogeneic stem cell transplant
      • Autologous stem cell transplant
    • Visitors
  • For health professionals
    • What we do
      • Cancer types & treatment
      • ONJCRI Testing Services
    • Referral
      • Referral for treatment
      • Referral to palliative care
    • Careers at Austin Health
  • Research
    • About us
    • Cancer Clinical Trials
    • Psycho-Oncology research
    • Olivia Newton-John Cancer Research Institute
  • About
    • Maps & directions
    • A public hospital with a difference
    • Dame Olivia Newton-John
    • Contact us
  • Ways to help
    • Ways to help today
      • Leave a gift in your Will
      • Support research
      • USA Donations
      • Become a hero today
    • Get Involved
      • Attend an event
      • Corporate partnerships
      • Volunteering
      • Dry July
    • How your gift helps
      • Why I give
      • People you've helped
    • We'll be here for you...but we need your help

Shopping Cart

There are no products in your cart.
Tom John laboratories2153 600px

A/Prof. Tom John

MEDICAL ONCOLOGIST | SENIOR CLINICAL RESEARCH FELLOW

More about A/Prof. Tom John

I have a unique opportunity to interface between the laboratory and the clinic. I can take a clinical problem, research it further in the lab and then take it back into the clinic. This means I can find solutions to clinical problems sooner.

My medical oncology areas of responsibility involve management of patients with lung cancer and familial cancers. My research interests currently involve the development and validation of Molecular Predictive and Prognostic Markers in Non-Small Cell Lung Cancer and the performance of clinical trials evaluating targeted biologic agents and small molecule inhibitors in lung cancer.

I recently published a study demonstrating that Cancer Testis (CT) antigens are not only poor prognostic markers, but also predict tumours likely to respond to chemotherapy. What is unclear is whether inducing these antigens to be expressed using demethylating agents also increases the likelihood of response to chemotherapy. I am using cell lines and xenografts to establish whether this observation can be used to clinically improve treatments for patients with lung cancer. I am also involved mesothelioma sequencing studies and the investigation of novel biomarkers that correlate with clinical endpoints.

Education

PhD, Medicine, University of Melbourne, Australia, 2008 

Fellowship of The Royal Australasian College of Physicians, Medical Oncology, 2005 

Bachelor of Medicine & Bachelor of Surgery, Monash University, Australia, 1996

Achievements

Merit award, American Society of Clinical Oncology, 2010 

Victorian Cancer Agency Clinical Research Fellowship, 2010 

Novartis Oncology Young Canadian Investigator Award, 2009-2010 

ASCO Cancer Foundation Merit Award, 2009 

International Association for the Study of Lung Cancer Fellowship, 2008 

AACR-Glaxo-Smith-Kline outstanding clinical scholar Award, 2008 

ASCO Cancer Foundation Merit Award, 2007

Medical Oncology Group Australia Travel Grant, 2007 

Australian Microarray and Associated Technologies Oral presenter Award, 2006

 

E: tom.john@onjcri.org.au

  • Home
  • Ways to help
  • Patients & family
  • For health professionals
  • Research
  • News
  • About
  • ONJ-events
  • Research
AustinHealth_Logo logo-onjcri
 
Partnership

A partnership between Austin Health and the Olivia Newton-John Cancer Research Institute.

Connect with us

Keep up to date with what’s happening at the ONJ Centre.

   

Call us

03 9496 5000

Calling from overseas

+613 9496 5000

Address

145 Studley Road (On the corner of Studley Rd and Bell St) Heidelberg, Victoria, Australia.